Better Therapeutics, Inc. (BTTX)
BTTX has a market cap or net worth of $85.90 million. The enterprise value is $121.86 million.
BTTX has 23.60 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||+0.72%|
|Owned by Insiders (%)||67.97%|
|Owned by Institutions (%)||24.82%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 1.14, with a Debt / Equity ratio of n/a.
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||n/a|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -65.15% in the last 52 weeks. The beta is 0.03, so BTTX's price volatility has been lower than the market average.
|52-Week Price Change||-65.15%|
|50-Day Moving Average||5.04|
|200-Day Moving Average||8.51|
|Average Volume (30 Days)||2,365,180|
Short Selling Information
|Short % of Shares Out||1.13%|
|Short % of Float||4.50%|
|Short Ratio (days to cover)||0.97|
|Earnings Per Share (EPS)||-$6.25|
The company has $3.23 million in cash and $39.19 million in debt, giving a net cash position of -$35.96 million or -$1.52 per share.
|Cash & Cash Equivalents||3.23M|
|Net Cash Per Share||-$1.52|
|Book Value Per Share||-2.43|
|Operating Cash Flow||n/a|
|Free Cash Flow||n/a|
|FCF Per Share||n/a|
Dividends & Yields
BTTX does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|